MONOAMINOOXIDASE INHIBITORS, THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION

摘要

FIELD: medicine. ^ SUBSTANCE: invention refers to therapeutic agents and concerns a therapeutic agents used for treatment of the patients suffering from diseases caused by monoaminooxidase overactivity and representing polyprenols of formula (1). The content of polyprenols of formula (1) where n=8-20 in the specified agent is 0.1 to 80%. Also there is disclosed method for treatment of the patients suffering from diseases caused by monoaminooxidase overactivity, characterised that a patient takes one or more doses of polyprenols of formula (1) in amount 1 to 150 mg a day (1). ^ EFFECT: invention allows extending range of therapeutic agents for treatment of the patients suffering from diseases caused by monoaminooxidase overactivity. ^ 4 cl, 8 tbl, 12 ex